Procaps Group, S.A. (PROCW)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 462.06 Million USD | -7.67% |
| 2021 | 500.47 Million USD | -18.52% |
| 2020 | 614.21 Million USD | 5.59% |
| 2019 | 581.67 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 458.69 Million USD | 5.07% |
| 2023 Q1 | 436.54 Million USD | -5.52% |
| 2023 Q3 | 460.1 Million USD | 0.31% |
| 2022 FY | 462.06 Million USD | -7.67% |
| 2022 Q1 | 502.92 Million USD | 0.49% |
| 2022 Q4 | 462.06 Million USD | -4.07% |
| 2022 Q2 | 499.76 Million USD | -0.63% |
| 2022 Q3 | 481.68 Million USD | -3.62% |
| 2021 Q1 | 611.41 Million USD | -0.46% |
| 2021 FY | 500.47 Million USD | -18.52% |
| 2021 Q4 | 500.47 Million USD | 16.81% |
| 2021 Q3 | 428.44 Million USD | -31.83% |
| 2021 Q2 | 628.49 Million USD | 2.79% |
| 2020 Q4 | 614.21 Million USD | 0.0% |
| 2020 FY | 614.21 Million USD | 5.59% |
| 2019 FY | 581.67 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 947.87 Million USD | 51.253% |
| China SXT Pharmaceuticals, Inc. | 9.19 Million USD | -4924.296% |
| Embecta Corp. | 2.03 Billion USD | 77.306% |
| Pacira BioSciences, Inc. | 704.25 Million USD | 34.39% |
| PainReform Ltd. | 2.69 Million USD | -17070.754% |
| Sunshine Biopharma, Inc. | 6.13 Million USD | -7425.979% |
| SCYNEXIS, Inc. | 55.45 Million USD | -733.3% |
| Journey Medical Corporation | 56.49 Million USD | -717.829% |
| Safety Shot Inc | 3.89 Million USD | -11772.039% |
| Alpha Teknova, Inc. | 38.55 Million USD | -1098.581% |
| Bright Green Corporation | 6.43 Million USD | -7077.038% |
| Alvotech | 1.88 Billion USD | 75.456% |
| ANI Pharmaceuticals, Inc. | 471.67 Million USD | 2.037% |
| Aquestive Therapeutics, Inc. | 163.9 Million USD | -181.91% |
| Cosmos Health Inc. | 30.25 Million USD | -1427.36% |
| Dynavax Technologies Corporation | 375.02 Million USD | -23.209% |
| Esperion Therapeutics, Inc. | 660.79 Million USD | 30.074% |
| Intra-Cellular Therapies, Inc. | 136.87 Million USD | -237.592% |
| Sunshine Biopharma, Inc. | 6.13 Million USD | -7425.979% |
| Theratechnologies Inc. | 98.63 Million USD | -368.44% |
| Harrow Health, Inc. | 241.75 Million USD | -91.131% |
| Sonoma Pharmaceuticals, Inc. | 8.75 Million USD | -5177.124% |
| Biofrontera Inc. | 23.13 Million USD | -1896.91% |
| DURECT Corporation | 30.4 Million USD | -1419.651% |
| Supernus Pharmaceuticals, Inc. | 487.46 Million USD | 5.21% |
| Cronos Group Inc. | 43.73 Million USD | -956.485% |
| OptiNose, Inc. | 194.33 Million USD | -137.767% |
| Ironwood Pharmaceuticals, Inc. | 817.36 Million USD | 43.469% |
| Kala Pharmaceuticals, Inc. | 48.44 Million USD | -853.793% |
| RedHill Biopharma Ltd. | 20.97 Million USD | -2102.604% |
| Organogenesis Holdings Inc. | 181.36 Million USD | -154.775% |
| Guardion Health Sciences, Inc. | 3.77 Million USD | -12149.432% |
| Cumberland Pharmaceuticals Inc. | 52.51 Million USD | -779.852% |
| Radius Health, Inc. | 804.29 Million USD | 42.55% |
| Universe Pharmaceuticals INC | 13.75 Million USD | -3259.415% |
| ProPhase Labs, Inc. | 42.54 Million USD | -986.087% |
| Phibro Animal Health Corporation | 725.54 Million USD | 36.315% |
| Procaps Group S.A. | 462.06 Million USD | 0.0% |
| TherapeuticsMD, Inc. | 14.02 Million USD | -3195.286% |
| Viatris Inc. | 27.21 Billion USD | 98.302% |
| Rockwell Medical, Inc. | 30.88 Million USD | -1396.228% |
| Aytu BioPharma, Inc. | 90.37 Million USD | -411.253% |
| SIGA Technologies, Inc. | 57.97 Million USD | -696.976% |
| Tilray Brands, Inc. | 892.11 Million USD | 48.206% |
| Lifecore Biomedical, Inc. | 219.8 Million USD | -110.221% |
| Shineco, Inc. | 47.6 Million USD | -870.69% |
| PetIQ, Inc. | 645.22 Million USD | 28.387% |
| Regencell Bioscience Holdings Limited | 219.51 Thousand USD | -210396.465% |
| Incannex Healthcare Limited | 5.83 Million USD | -7825.643% |
| Neurocrine Biosciences, Inc. | 1.01 Billion USD | 54.673% |
| Alimera Sciences, Inc. | 107.35 Million USD | -330.412% |
| Silver Spike Investment Corp. | 3 Million USD | -15251.859% |
| Assertio Holdings, Inc. | 148.41 Million USD | -211.331% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.89 Million USD | -24270.967% |
| Petros Pharmaceuticals, Inc. | 21.31 Million USD | -2067.714% |
| Clever Leaves Holdings Inc. | 7.02 Million USD | -6476.502% |
| Cyclo Therapeutics, Inc. | 8.49 Million USD | -5342.121% |
| Avadel Pharmaceuticals plc | 173.38 Million USD | -166.493% |
| Hempacco Co., Inc. | 18.82 Million USD | -2354.867% |
| Talphera, Inc. | 6.29 Million USD | -7246.025% |
| Alvotech | 1.88 Billion USD | 75.456% |
| Eagle Pharmaceuticals, Inc. | 172.6 Million USD | -167.709% |
| Lantheus Holdings, Inc. | 835.25 Million USD | 44.68% |
| Currenc Group, Inc. | 177.67 Million USD | -160.061% |
| Kamada Ltd. | 109.96 Million USD | -320.18% |
| Indivior PLC | 1.95 Billion USD | 76.319% |
| Evoke Pharma, Inc. | 9.64 Million USD | -4689.19% |
| Flora Growth Corp. | 17.22 Million USD | -2582.993% |
| Cyclo Therapeutics, Inc. | 8.49 Million USD | -5342.121% |
| Evolus, Inc. | 209.68 Million USD | -120.359% |
| HUTCHMED (China) Limited | 536.38 Million USD | 13.856% |
| Amphastar Pharmaceuticals, Inc. | 873.49 Million USD | 47.101% |
| Akanda Corp. | 12.66 Million USD | -3547.243% |